| Abstract: | A mononuclear iron(II) complex, [Fe(phen)3]Cl2 ( 1 ) (phen =1,10‐phenanthroline), has been synthesized in crystalline phase and characterized using various spectroscopic techniques including single crystal X‐ray diffraction. Crystal structure analysis revealed that 1 crystallizes in a monoclinic system with C2/m space group. Complex 1 acts as a functional model for a biomimetic catalyst promoting the aerobic oxidation of 3,5‐di‐tert ‐butylcatechol (3,5‐DTBC) through radical pathways with a significant turnover number (k cat =3.55 × 103 h−1) and exhibits catechol dioxygenase activity towards the same 3,5‐DTBC substrate at room temperature in oxygen‐saturated ethanol medium. The existence of an isobestic point at 610 nm from spectrophotometric data indicates the presence of Fe3+ −3,5‐DTBC adduct favouring an enzyme–substrate binding phenomenon. Upon stoichiometric addition of 3,5‐DTBC pretreated with two equivalents of triethylamine to the iron complex, two catecholate‐to‐iron(III) ligand‐to‐metal charge transfer bands (575 and 721 nm) are observed and the in situ generated catecholate intermediate reacts with dioxygen (k obs =9.89 × 10−4 min−1) in ethanol medium to afford exclusively intradiol cleavage products along with a small amount of benzoquinone, and a small amount of extradiol cleavage products, which provide substantial evidence for a substrate activation mechanism. Copyright © 2016 John Wiley & Sons, Ltd. |
